NEJM Interviews
NEJM Group
Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
Episodes
Mentioned books
Aug 22, 2018 • 9min
NEJM Interview: Dr. Jonathan Oberlander on the results of Republican opposition to the Affordable Care Act.
Dr. Jonathan Oberlander is a professor of social medicine and health policy and management at the University of North Carolina at Chapel Hill. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. J. Oberlander. The Republican War on Obamacare - What Has It Achieved? N Engl J Med 2018;379:703-5.
Aug 15, 2018 • 10min
NEJM Interview: Dr. Eduardo Bruera on the treatment of pain during a severe shortage of parenteral opioids.
Dr. Eduardo Bruera is chair of the Department of Palliative, Rehabilitation and Integrative Medicine at the University of Texas M.D. Anderson Cancer Center. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. E. Bruera. Parenteral Opioid Shortage - Treating Pain during the Opioid-Overdose Epidemic. N Engl J Med 2018;379:601-3.
Aug 8, 2018 • 10min
NEJM Interview: Dr. Rebecca Haffajee on the conflict between federal and state marijuana laws.
Dr. Rebecca Haffajee is an assistant professor of health management and policy at the University of Michigan School of Public Health. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. R.L. Haffajee, R.J. MacCoun, and M.M. Mello. Behind Schedule - Reconciling Federal and State Marijuana Policy. N Engl J Med 2018;379:501-4.
Aug 1, 2018 • 12min
NEJM Interview: Dr. Diana Bianchi on the use of cell-free DNA testing to screen for fetal chromosome abnormalities.
Dr. Diana Bianchi is from the National Human Genome Research Institute at the NIH in Bethesda, Maryland. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.W. Bianchi and R.W.K. Chiu. Sequencing of Circulating Cell-free DNA during Pregnancy. N Engl J Med 2018;379:464-73.
Aug 1, 2018 • 8min
NEJM Interview: Dr. John Maa on his proposal for a Surgeon General’s report on firearm injuries and violence that could change the U.S. debate about guns.
Dr. John Maa is chief of the Division of General and Acute Care Surgery at Marin General Hospital in California. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. J. Maa and A. Darzi. Firearm Injuries and Violence Prevention - The Potential Power of a Surgeon General’s Report. N Engl J Med 2018;379:408-10.
Jul 25, 2018 • 8min
NEJM Interview: Dr. Lisa Rosenbaum on how emotion and risk perception affect decision making in public health and medicine.
Dr. Lisa Rosenbaum discusses ethical dilemmas in public health, emphasizing risk perception in decision-making. Topics include trolleyology, the Dengue vaccine dilemma, and societal vs personal safety in vaccine perception.
Jul 18, 2018 • 7min
NEJM Interview: Dr. Charlotte Haug on a new European privacy law that gives consumers, including patients, more explicit control of their own data.
Dr. Charlotte Haug is an international correspondent for the Journal. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. C.J. Haug. Turning the Tables - The New European General Data Protection Regulation. N Engl J Med 2018;379:207-9.
Jul 11, 2018 • 7min
NEJM Interview: Dr. Bernard Lo on a herpes vaccine trial that reportedly flouted established protections for research participants.
Dr. Bernard Lo is the President of the Greenwall Foundation. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. B. Lo. A Parallel Universe of Clinical Trials. N Engl J Med 2018;379:101-3.
Jul 4, 2018 • 9min
NEJM Interview: Dr. Carl June on chimeric antigen receptor therapy.
Dr. Carl June is the director of the Center for Cellular Immunotherapies at the University of Pennsylvania Perelman School of Medicine. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. C.H. June and M. Sadelain. Chimeric Antigen Receptor Therapy. N Engl J Med 2018;379:64-73.
Jul 4, 2018 • 7min
NEJM Interview: Dr. Brendan Saloner on increasing access to medication for treatment of opioid use disorder.
Dr. Brendan Saloner is an assistant professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. B. Saloner, K.B. Stoller, and G.C. Alexander. Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment. N Engl J Med 2018;379:4-6. S.E. Wakeman and M.L. Barnett. Primary Care and the Opioid-Overdose Crisis - Buprenorphine Myths and Realities. N Engl J Med 2018;379:1-4. J.H. Samet, M. Botticelli, and M. Bharel. Methadone in Primary Care - One Small Step for Congress, One Giant Leap for Addiction Treatment. N Engl J Med 2018;379:7-8.
